Adult T-cell lymphomas/leukaemias Completed Phase 2 Trials for Cisplatin (DB00515)

Also known as: ATLL / Adult T-Cell Leukemia-Lymphoma / Leukemia-Lymphoma, Adult T-Cell / Adult T-cell lymphoma/leukaemia / Adult T-cell leukemia / Adult T-cell lymphoma/leukemia (HTLV-1-associated) with failed remission / Adult T-cell lymphoma/leukaemia NOS / Adult T-cell lymphoma/leukemia / T-cell lymphoblastic leukemia acute / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / T-cell type acute leukemia / T-cell type acute leukaemia / T-cell lymphoblastic leukaemia acute

DBCOND0025994 (Adult T-cell lymphomas/leukaemias)Completed2 IdentifierTitlePurposeDrugs
NCT01626664KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)Treatment